We will continue to drive for at least 10 to 12 percent annual earnings growth.

Ultimately, it will be higher prices for the consumer.

Accelerating the growth in life sciences is key to our strategy to becoming a faster-growing, more profitable, less cyclical company,

More of our growth over the 5 to 10 years will come internationally than nationally. Having their expertise as part of the team effort really gives us a leg up.

Our view of the global economy suggests several more quarters of low volume growth and continued price pressure, ... Lower raw material costs and more favorable currency comparison. combined with results from our productivity focus should all contribute to our ability to weather this cycle more favorably than in the past.

We knew it would be a difficult operating environment in the first quarter, and I am very encouraged by the better than expected performance of our company. I am especially pleased with how our people delivered these results. We are fully committed to growing revenue, controlling costs and improving return on assets across all of our businesses.